Skip to main content
. 2017 Apr;72(4):218–223. doi: 10.6061/clinics/2017(04)05

Table 5.

Therapeutic approach used in 20 patients in regular follow-up.

G1 G2 Total
N %
Surgerya+SRLsb 7 2 9 45.0
Surgery+ratiotherapy+SRLs 2 1 3 15.0
SRLs+cabergoline 1 2 3 15.0
Surgery+radiotherapy+SRLs+cabergoline 0 1 1 5.0
SRLs 2 0 2 10.0
Surgery 0 1 1 5.0
Surgery+radiotherapy 0 1 1 5.0

a: transphenoidal surgery

b: SRLs= somatostatin receptor ligands.